Wells Fargo’s Trevi Therapeutics TRVI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $225K | Buy |
41,171
+75
| +0.2% | +$410 | ﹤0.01% | 4321 |
|
|
2025
Q1 | $258K | Buy |
41,096
+8,046
| +24% | +$50.6K | ﹤0.01% | 4089 |
|
|
2024
Q4 | $136K | Buy |
33,050
+9,562
| +41% | +$39.4K | ﹤0.01% | 4537 |
|
|
2024
Q3 | $78.4K | Buy |
23,488
+10
| +0% | +$33 | ﹤0.01% | 4755 |
|
|
2024
Q2 | $70K | Buy |
23,478
+6,639
| +39% | +$19.8K | ﹤0.01% | 4781 |
|
|
2024
Q1 | $58.1K | Buy |
16,839
+3,877
| +30% | +$13.4K | ﹤0.01% | 4816 |
|
|
2023
Q4 | $17.4K | Buy |
12,962
+2,687
| +26% | +$3.6K | ﹤0.01% | 5251 |
|
|
2023
Q3 | $22.4K | Sell |
10,275
-5,562
| -35% | -$12.1K | ﹤0.01% | 5188 |
|
|
2023
Q2 | $37.9K | Buy |
15,837
+15,572
| +5,876% | +$37.2K | ﹤0.01% | 5245 |
|
|
2023
Q1 | $490 | Buy |
265
+4
| +2% | +$7 | ﹤0.01% | 6240 |
|
|
2022
Q4 | $504 | Buy |
261
+122
| +88% | +$236 | ﹤0.01% | 6057 |
|
|
2022
Q3 | $0 | Sell |
139
-27
| -16% | – | ﹤0.01% | 7044 |
|
|
2022
Q2 | $0 | Buy |
166
+93
| +127% | – | ﹤0.01% | 7164 |
|
|
2022
Q1 | $0 | Hold |
73
| – | – | ﹤0.01% | 7240 |
|
|
2021
Q4 | $0 | Buy |
73
+27
| +59% | – | ﹤0.01% | 7222 |
|
|
2021
Q3 | $0 | Buy |
46
+13
| +39% | – | ﹤0.01% | 7143 |
|
|
2021
Q2 | $0 | Buy |
33
+9
| +38% | – | ﹤0.01% | 7029 |
|
|
2021
Q1 | $0 | Buy |
24
+2
| +9% | – | ﹤0.01% | 6957 |
|
|
2020
Q4 | $0 | Hold |
22
| – | – | ﹤0.01% | 6639 |
|
|
2020
Q3 | $0 | Sell |
22
-14
| -39% | – | ﹤0.01% | 6485 |
|
|
2020
Q2 | $0 | Hold |
36
| – | – | ﹤0.01% | 6398 |
|
|
2020
Q1 | $0 | Buy |
+36
| New | – | ﹤0.01% | 6368 |
|